Dominik Gaser has 20 years of experience in
pharmaceutical industry, predominantly in the field of cell line development
for biological therapeutics.
He joined Lek Pharmaceuticals, now Novartis Company in
2001. His primary field of work has been establishment of cell line development
platform and constant improvement through implementation of new technologies,
digitalization and automatization of the development processes.
In the current role he leads Cell and Molecular
Biology group in Menges Slovenia and scientific group focusing in successful
development of biological therapeutics. In expert role he also evaluates
external opportunities through business development and licencing activities.
Dominik Gaser has pharmaceutical background and holds
PhD from Faculty of Pharmacy in Ljubljana and MBA from IEDC School of